Scientific partnership paves the way for 4D bioprinted liver tissue

Servier (Suresnes, France) and Poietis (Pessac, France) have announced a scientific partnership, which will see the development and production of 4D bioprinted liver tissue in an effort to improve the detection of drug-induced liver lesions in early preclinical trial phases. Servier (Suresnes, France) and Poietis (Pessac, France) have announced a scientific partnership for the development and production of 4D bioprinted liver tissues. The partnership will see the companies combining Servier's international pharmaceutical knowledge with Poietis' 4D bioprinting technology, in an effort to improve the detection of drug-induced liver lesions in early preclinical trial phases. These lesions are rarely seen in...